{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Even+protein&page=2", "query": { "intervention": "Even protein", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Even+protein&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-29T05:34:42.992Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00002556", "title": "Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Stage I Multiple Myeloma", "Stage II Multiple Myeloma", "Stage III Multiple Myeloma" ], "interventions": [ { "name": "vincristine sulfate", "type": "DRUG" }, { "name": "carmustine", "type": "DRUG" }, { "name": "melphalan", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "prednisone", "type": "DRUG" }, { "name": "recombinant interferon alfa-2b", "type": "BIOLOGICAL" }, { "name": "laboratory biomarker analysis", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 312, "start_date": "1994-07", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-05-31", "last_synced_at": "2026-09-29T05:34:42.992Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002556" }, { "nct_id": "NCT00669877", "title": "Rituximab and Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) for Burkitt's and Burkitt's -Like Leukemia/Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Burkitt's Lymphoma", "Burkitt'S-like Lymphoma" ], "interventions": [ { "name": "Rituximab", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "G-CSF", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 56, "start_date": "2002-08", "completion_date": "2015-10", "has_results": true, "last_update_posted_date": "2018-05-16", "last_synced_at": "2026-09-29T05:34:42.992Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00669877" }, { "nct_id": "NCT04409587", "title": "Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Type1 Diabetes Mellitus" ], "interventions": [ { "name": "Aspart", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mountain Diabetes and Endocrine Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 59, "start_date": "2018-04-12", "completion_date": "2020-11-01", "has_results": false, "last_update_posted_date": "2021-02-24", "last_synced_at": "2026-09-29T05:34:42.992Z", "location_count": 1, "location_summary": "Asheville, North Carolina", "locations": [ { "city": "Asheville", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04409587" }, { "nct_id": "NCT05664789", "title": "Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Autism Spectrum Disorder" ], "interventions": [ { "name": "N acetyl cysteine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "3 Years to 12 Years" }, "enrollment_count": 144, "start_date": "2023-04-26", "completion_date": "2028-07-31", "has_results": false, "last_update_posted_date": "2026-05-15", "last_synced_at": "2026-09-29T05:34:42.992Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05664789" }, { "nct_id": "NCT01125176", "title": "Alternating Thalidomide and Lenalidomide Therapy Plus Rituximab (ThRiL) as Initial Treatment for Patients With CLL", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Lymphocytic Leukemia" ], "interventions": [ { "name": "thalidomide", "type": "DRUG" }, { "name": "lenalidomide", "type": "DRUG" }, { "name": "rituximab", "type": "BIOLOGICAL" } ], "intervention_types": [ "DRUG", "BIOLOGICAL" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2012-03-30", "completion_date": "2020-12-29", "has_results": true, "last_update_posted_date": "2022-01-21", "last_synced_at": "2026-09-29T05:34:42.992Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01125176" }, { "nct_id": "NCT06126354", "title": "Dexamethasone/Pancreatic Clamp P&F", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Insulin Resistance", "Prediabetic State", "Non-Alcoholic Fatty Liver Disease", "Overweight and Obesity" ], "interventions": [ { "name": "Insulin human", "type": "DRUG" }, { "name": "Octreotide Acetate", "type": "DRUG" }, { "name": "Glucagon", "type": "DRUG" }, { "name": "Human Growth Hormone", "type": "DRUG" }, { "name": "Dexamethasone Oral", "type": "DRUG" }, { "name": "[6,6-2H2] D-glucose", "type": "OTHER" }, { "name": "20% D-glucose (aq)", "type": "DRUG" }, { "name": "BOOST Plus", "type": "DIETARY_SUPPLEMENT" }, { "name": "Harvard Apparatus PHD ULTRA CP syringe pump", "type": "DEVICE" }, { "name": "Yellow Springs Instruments (YSI) 2500 Biochemistry Glucose/Lactate Analyzer", "type": "DEVICE" }, { "name": "Normal saline", "type": "OTHER" }, { "name": "Human albumin", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER", "DIETARY_SUPPLEMENT", "DEVICE" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2024-07-01", "completion_date": "2026-03-31", "has_results": false, "last_update_posted_date": "2024-07-10", "last_synced_at": "2026-09-29T05:34:42.992Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06126354" }, { "nct_id": "NCT03202069", "title": "Protein Eating Patterns and Weight Loss", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Obesity" ], "interventions": [ { "name": "Even protein", "type": "OTHER" }, { "name": "Skewed protein", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "USDA Grand Forks Human Nutrition Research Center", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "44 Years", "sex": "FEMALE", "summary": "20 Years to 44 Years · Female only" }, "enrollment_count": 45, "start_date": "2017-10-02", "completion_date": "2023-04-14", "has_results": false, "last_update_posted_date": "2025-04-16", "last_synced_at": "2026-09-29T05:34:42.992Z", "location_count": 1, "location_summary": "Grand Forks, North Dakota", "locations": [ { "city": "Grand Forks", "state": "North Dakota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03202069" }, { "nct_id": "NCT07296770", "title": "An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Postsurgical Pain Management", "Postsurgical Pain, Chronic", "Opioid Use After Surgery" ], "interventions": [ { "name": "TPS-Select", "type": "DEVICE" }, { "name": "Pharmacologic Pain Management", "type": "DRUG" }, { "name": "Interventional Pain Procedures", "type": "PROCEDURE" }, { "name": "Psychological Management and Pain Education", "type": "BEHAVIORAL" }, { "name": "Physical Therapy", "type": "BEHAVIORAL" } ], "intervention_types": [ "DEVICE", "DRUG", "PROCEDURE", "BEHAVIORAL" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 126, "start_date": "2026-10-01", "completion_date": "2028-07-01", "has_results": false, "last_update_posted_date": "2026-07-13", "last_synced_at": "2026-09-29T05:34:42.992Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07296770" }, { "nct_id": "NCT06073080", "title": "Recovery Protein Nutrition as a Countermeasure for Anabolic Resistance Following Sleep Loss", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sleep, Inadequate" ], "interventions": [ { "name": "Protein Nutrition During Recovery", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "United States Army Research Institute of Environmental Medicine", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "39 Years", "sex": "ALL", "summary": "18 Years to 39 Years" }, "enrollment_count": 20, "start_date": "2024-03-21", "completion_date": "2024-11-04", "has_results": false, "last_update_posted_date": "2026-01-21", "last_synced_at": "2026-09-29T05:34:42.992Z", "location_count": 1, "location_summary": "Natick, Massachusetts", "locations": [ { "city": "Natick", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06073080" }, { "nct_id": "NCT02237859", "title": "Vancomycin Prophylaxis in Recurrent Clostridium Difficile Infection", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Clostridium Difficile Infection" ], "interventions": [ { "name": "Vancomycin", "type": "DRUG" }, { "name": "fruit juice/placebo", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Corewell Health West", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 140, "start_date": "2014-08", "completion_date": "2016-08", "has_results": false, "last_update_posted_date": "2014-09-11", "last_synced_at": "2026-09-29T05:34:42.992Z", "location_count": 1, "location_summary": "Grand Rapids, Michigan", "locations": [ { "city": "Grand Rapids", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02237859" } ] }